Dr. Meera Ramakrishnan, MD

Dr. Ramakrishnan practices at Retinal Consultants Medical Group in Sacramento, California.

Dr. Ramakrishnan's NPI, 1659802387, was assigned on March 24, 2017. Dr. Ramakrishnan graduated from Perelman School of Medicine - Philadelphia in 2017. Dr. Ramakrishnan holds California license A186915.

Dr. Ramakrishnan's primary practice is Retinal Consultants Medical Group, at 3 Park Center Dr, Sacramento, CA 95825 in Sacramento County. The practice phone is (209) 549-8444.

Dr. Ramakrishnan's primary practice is Retinal Consultants Medical Group in Sacramento, California. Dr. Ramakrishnan is also affiliated with Dignity Health - Mercy General Hospital. Dmand AI also links Dr. Ramakrishnan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramakrishnan practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Ramakrishnan's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Ramakrishnan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ramakrishnan's licenses on file in 3 states: California, New York and Pennsylvania.

Dmand AI lists age-related macular degeneration, glaucoma, retinal detachment and retinal occlusion among the conditions Dr. Ramakrishnan treats.

CMS data shows 33,952 Medicare services from Dr. Ramakrishnan across 23 procedure codes in 2024, for 1,134 Medicare patients. Medicare paid $2,300,770 for them.

CMS counts 1,134 Medicare patients who saw Dr. Ramakrishnan in 2024. The largest group is 65 to 74, with 403 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramakrishnan's median patient age at 66, with 52% women.

In 2024, Dr. Ramakrishnan wrote 451 Medicare Part D claims for 184 patients. 61% of them were for generic drugs. CMS names the drug for 378 of them, across 8 drugs with 11 or more claims each, at $11,987 in total drug cost. In 2023, CMS named 33 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ramakrishnan for performance year 2024, reported as part of a group. Dr. Ramakrishnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Ramakrishnan, published from 2017 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Retina and Angiogenesis Inhibitors. Dr. Ramakrishnan has published most often in Am J Ophthalmol Case Rep. Dr. Ramakrishnan's most frequent co-authors are Robin A. Vora, MD, Victoria Marie Addis, MD and Amanda Young Lehman, MD.

CMS Open Payments shows 44 general payments to Dr. Ramakrishnan from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $710. It also lists 2 research payments totaling $3,346 in 2022.

Dr. Ramakrishnan graduated from Perelman School of Medicine - Philadelphia in 2017.

Dr. Ramakrishnan is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.